Fundraising FoxAltium Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Gemini Therapeuticsgeminitherapeutics.comApr 2016
Precision medicine company developing therapeutics for genetically-defined age-related macular degeneration.
BiotechCambridge, US
James McLaughlin(Executive Officer, Director)in
BoardJean George(Director)Jason Rhodes(Director)inCarl Gordon(Director)in
Co-investorsLightstone VenturesAtlas VentureOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.